Florida Cancer Specialists Press Release

FOR IMMEDIATE RELEASE

Florida Cancer Specialists Rolls Out “Next Generation” Fixed and Mobile PET/CT Scanners

First in Nation to Have Siemens’ Latest Imaging Technology


Fort Myers, FL – July 11, 2016……… Florida Cancer Specialists & Research Institute (FCS) and Siemens Healthcare are pleased to announce that FCS’s Gladiolus office in Fort Myers, FL is the first community oncology location in the United States to have Siemens’ Biograph Horizon PET/CT Scanner, which utilizes a cutting-edge molecular imaging technology that enables faster PET/CT scans, lower injected dose and better image quality to support the identification of extremely small lesions.

FCS CEO Brad Prechtl said, “The Horizon’s high image quality helps our radiologists and physicians determine more accurate disease staging and an effective treatment strategy. Plus, with this new technology, we are now able to reduce the time it takes to do a scan, so that our patients are more comfortable. Gladiolus is the first location in our network to have this next-generation in PET/CT imagining technology; we are in the process of installing the fixed Horizon scanners in four other locations.”

FCS President and Founder Dr. William Harwin added,“We are also very excited to have another advanced technology in our mobile PET/CT units. We just introduced our first mobile unit with the Siemens mCT20 scanner, which is already accommodating patients in several locations in Pasco and Hernando Counties, and we will add two additional mobile units in the next few months. We are extremely proud to be able to offer our patients a new standard in imaging technology.”

Florida Cancer Specialists’ mCT20 units are the first on a mobile platform in the Southeast and offer several advantages for both clinicians and patients. Most notably, this scanner has a larger bore; the bore is the “doughnut” that patient is inserted into for scanning. The larger size allows for greater patient comfort and helps to reduce claustrophobia. Plus, the 20 slice CT allows for faster speed while scanning, thus reducing motion and increasing resolution of images.

Siemens PET/CT technology delivers excellent lesion detectability, spatial resolution and quantification accuracy. These advances in molecular imaging help our physicians learn critical details that result in meaningful improvements in our patient outcomes.

###


About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 180 physicians, 150 nurse practitioners and physician assistants and over 90 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 70% of new cancer drugs approved in 2015 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast in Daytona/Palm Coast, Vero Beach/Sebastian and in Palm Beach County.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

* Prior to approval

For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer -
770.365.6168

Double Diamond Marketing + Communications
Angela Evans -
615.254.1515

Ganick Communications, Inc.Double Diamond Marketing + Communications
Elaine Ganick -
615.377.7877